AbCellera

Read more
Carl Hansen's photo - CEO of AbCellera

CEO

Carl Hansen

CEO Approval Rating

90/100

Founded:

2012

Status:

PublicIndependent CompanyNASDAQABCL

ABCELLERA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Berkeley Lights is AbCellera's #1 competitor. Berkeley Lights was founded in Emeryville, California} in 2011. Like AbCellera, Berkeley Lights also competes in the Biotechnology industry. Compared to AbCellera, Berkeley Lights generates $64.1M more revenue.

Ligand Pharmaceuticals is one of AbCellera's top competitors. Ligand Pharmaceuticals was founded in 1987 in San Diego, California. Like AbCellera, Ligand Pharmaceuticals also operates in the Biotechnology industry. Ligand Pharmaceuticals generates $203.3M more revenue than AbCellera.

Sphere Fluidics is a top competitor of AbCellera. Sphere Fluidics was founded in 2010, and is headquartered in Cambridge, England. Sphere Fluidics operates in the Health Care Equipment industry. Sphere Fluidics generates $4.5M more revenue vs. AbCellera.

AbCellera Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$5.1M

AbCellera's revenue is the ranked 16th among it's top 10 competitors. The top 10 competitors average 2B. Over the last two quarters, AbCellera's revenue has grown by 4253.5%. Specifically, in Q1 2021's revenue was $202.7M; in Q1 2020, it was $4.7M.

AbCellera Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Trianni, Inc.

Nov 2020

Source »
$90M
Trianni develops an antibody discovery platform that offers DNA synthesis and genomic modification solutions to the pharmaceutical sector.

-

OrthoMab bispecific platform

Aug 2020

Source »
undisclosed
-

AbCellera Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Dec 2020
$483M

Series B
May 2020
$105M
Grant
May 2020
$175.6M
-
Equity
Mar 2020
$74.5M
-
Series A
Aug 2018
$10M

AbCellera Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Invetx is a biopharmaceutical company that develops and provides protein-based therapeutics for animal health conditions.
$10.3M
Sep 29, 2020
Series A
-

AbCellera News

AbCellera Press Releases

AbCellera Videos

Social Media

AbCellera Headquarters

2215 Yukon Street

Vancouver, British ColumbiaV5Y 0A1

604-559-9005

Driving Directions »

Trending Companies

AbCellera Summary

ABOUT

Overview

AbCellera is a pharmaceutical company that discovers and develops therapeutic antibodies for the treatment of viral infections. AbCellera was founded in 2012. AbCellera's headquarters is located in Vancouver, British Columbia, CA V5Y 0A1. It has raise...

CEO

AbCellera's CEO, Carl Hansen, currently has an approval rating of 90%. AbCellera's primary competitors are Berkeley Lights, Ligand Pharmaceuticals & Sphere Fluidics.

Frequently Asked Questions about AbCellera

  1. When was AbCellera founded?

    AbCellera was founded in 2012
  2. Who is AbCellera's CEO?

    AbCellera's CEO is Carl Hansen
  3. How much revenue does AbCellera generate?

    AbCellera generates $5.1M in revenue
  4. How much funding does AbCellera have?

    AbCellera has historically raised $849M in funding
  5. Where is AbCellera's headquarters?

    AbCellera's headquarters is in Vancouver British Columbia, CA
  1. How many employees does AbCellera have?

    AbCellera has 174 employees
  2. What sector does AbCellera operate in?

    AbCellera is in Biotechnology
  3. Who are AbCellera's competitors?

    AbCellera's top competitors are Berkeley Lights, Ligand Pharmaceuticals, Sphere Fluidics
  4. Who has AbCellera invested in?

    AbCellera's has invested in companies such as Invetx